BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Institute for Bioengineering of Catalonia - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://ibecbarcelona.eu
X-WR-CALDESC:Events for Institute for Bioengineering of Catalonia
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Madrid
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20160327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20161030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20170326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20171029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20180325T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20181028T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20191027T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20170303T100000
DTEND;TZID=Europe/Madrid:20170303T110000
DTSTAMP:20260405T234545
CREATED:20170213T103423Z
LAST-MODIFIED:20170213T103423Z
UID:95988-1488535200-1488538800@ibecbarcelona.eu
SUMMARY:IBEC Seminar: Maria Virumbrales
DESCRIPTION:“Development of microfluidic tools to reproduce and characterize the tumor microenvironment”\nMaria Virumbrales\, University of Zaragoza\nCompelling evidence over the years has demonstrated that the tumor microenvironment (TME) shapes tumor initiation\, development and response to therapy. This results in a high heterogeneity within the same cancer type\, and hinders the process of finding effective treatments.[1\,2] \nIn this context\, microfluidics has proven a worthy sum of techniques to create comprehensive and personalized cancer in vitro 3D models reproducing the TME in a more relevant fashion than traditional in vitro setups. \nMicrofluidics also permits a high degree of control over the setup\, combining different cell types in an orderly manner\, as well as different physical and biochemical cues. [3] Furthermore\, microfluidics facilitates optical inspection and diminishes sample sizes and reagent volumes needed for each experiment. Microfluidic devices are also compatible with high-throughput approaches\, which make them an interesting option for drug testing\, research and development.[4] \nHence\, we developed two microfluidic tumor models\, which we used to model and characterize different aspects of the TME. TME was characterized in terms of hypoxia\, proliferation rates\, reactive oxygen species concentration\, apoptosis rate and glucose uptake.[5] Moreover\, the influence of tumor cells on an endothelium was investigated. Furthermore\, we carried out pharmacodynamic and drug efficiency studies in these newly-established models. Thereafter\, we developed a simple enzymatic protocol to extract cells seeded in 3D from the microfluidic devices. Cells could be sorted by flow cytometry according to the expression of specific surface markers or by using different fluorescent stains. RNA was extracted for downstream quantification and gene profiling was carried out for the mentioned aspects of the tumor microenvironment. \nAll in all\, we developed two easy-to-use microfluidic models for personalized medicine capable of comprehensive reproduction of the TME\, which allows characterization of tumor signatures by means of microscopy and traditional benchtop methods. \n\nBalkwill FR\, Capasso M\, Hagemann T (2012) The tumor microenvironment at a glance. J Cell Sci 125: 5591-5596.\nKlemm F\, Joyce JA (2015) Microenvironmental regulation of therapeutic response in cancer. Trends Cell Biol 25: 198-213.\nSackmann EK\, Fulton AL\, Beebe DJ (2014) The present and future role of microfluidics in biomedical research. Nature 507: 181-189.\nDu G\, Fang Q\, den Toonder JMJ (2016) Microfluidics for cell-based high throughput screening platforms—A review. Analytica Chimica Acta 903: 36-50.\nAyuso JM\, Virumbrales-Munoz M\, Lacueva A\, Lanuza PM\, Checa-Chavarria E\, et al. (2016) Development and characterization of a microfluidic model of the tumour microenvironment. Sci Rep 6: 36086.\n\n 
URL:https://ibecbarcelona.eu/event/ibec-seminar-maria-virumbrales-2/
CATEGORIES:IBEC Seminar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20170303T100000
DTEND;TZID=Europe/Madrid:20170303T110000
DTSTAMP:20260405T234545
CREATED:20170213T103423Z
LAST-MODIFIED:20170215T152756Z
UID:27594-1488535200-1488538800@ibecbarcelona.eu
SUMMARY:IBEC Seminar: Maria Virumbrales
DESCRIPTION:“Development of microfluidic tools to reproduce and characterize the tumor microenvironment”\nMaria Virumbrales\, University of Zaragoza\nCompelling evidence over the years has demonstrated that the tumor microenvironment (TME) shapes tumor initiation\, development and response to therapy. This results in a high heterogeneity within the same cancer type\, and hinders the process of finding effective treatments.[1\,2] \nIn this context\, microfluidics has proven a worthy sum of techniques to create comprehensive and personalized cancer in vitro 3D models reproducing the TME in a more relevant fashion than traditional in vitro setups. \nMicrofluidics also permits a high degree of control over the setup\, combining different cell types in an orderly manner\, as well as different physical and biochemical cues. [3] Furthermore\, microfluidics facilitates optical inspection and diminishes sample sizes and reagent volumes needed for each experiment. Microfluidic devices are also compatible with high-throughput approaches\, which make them an interesting option for drug testing\, research and development.[4] \nHence\, we developed two microfluidic tumor models\, which we used to model and characterize different aspects of the TME. TME was characterized in terms of hypoxia\, proliferation rates\, reactive oxygen species concentration\, apoptosis rate and glucose uptake.[5] Moreover\, the influence of tumor cells on an endothelium was investigated. Furthermore\, we carried out pharmacodynamic and drug efficiency studies in these newly-established models. Thereafter\, we developed a simple enzymatic protocol to extract cells seeded in 3D from the microfluidic devices. Cells could be sorted by flow cytometry according to the expression of specific surface markers or by using different fluorescent stains. RNA was extracted for downstream quantification and gene profiling was carried out for the mentioned aspects of the tumor microenvironment. \nAll in all\, we developed two easy-to-use microfluidic models for personalized medicine capable of comprehensive reproduction of the TME\, which allows characterization of tumor signatures by means of microscopy and traditional benchtop methods. \n\nBalkwill FR\, Capasso M\, Hagemann T (2012) The tumor microenvironment at a glance. J Cell Sci 125: 5591-5596.\nKlemm F\, Joyce JA (2015) Microenvironmental regulation of therapeutic response in cancer. Trends Cell Biol 25: 198-213.\nSackmann EK\, Fulton AL\, Beebe DJ (2014) The present and future role of microfluidics in biomedical research. Nature 507: 181-189.\nDu G\, Fang Q\, den Toonder JMJ (2016) Microfluidics for cell-based high throughput screening platforms—A review. Analytica Chimica Acta 903: 36-50.\nAyuso JM\, Virumbrales-Munoz M\, Lacueva A\, Lanuza PM\, Checa-Chavarria E\, et al. (2016) Development and characterization of a microfluidic model of the tumour microenvironment. Sci Rep 6: 36086.\n\n 
URL:https://ibecbarcelona.eu/event/ibec-seminar-maria-virumbrales/
CATEGORIES:IBEC Seminar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20170306T120000
DTEND;TZID=Europe/Madrid:20170306T130000
DTSTAMP:20260405T234545
CREATED:20170222T083846Z
LAST-MODIFIED:20170222T083846Z
UID:96001-1488801600-1488805200@ibecbarcelona.eu
SUMMARY:IBEC Seminar: David Cahen
DESCRIPTION:Electron Transport across Peptides and Proteins\nProf. David Cahen\, Weizmann Institute of Science\nElectron transport (ETp)\, i.e.\, electronic conduction across peptides and proteins in a solid state–like configuration is surprisingly efficient\, and comparable to\, or at times even more efficient than via completely conjugated molecules of comparable length. Working with modified proteins and with homopeptides we find both cofactors and secondary structure to matter for ETp efficiency. An open question is if contact to the external world is the dominant factor\, or intra-protein transport. This is important\, also for electron transfer\, ET: nature regulates ET via redox chemistry\, i.e.\, injection and extraction of electrons; this is where ET and ETp are related\, because the analog in the latter is the coupling to the electrodes. In ET control over the process is achieved at the free energy price of a redox event\, but no redox process is required for ETp. This allows studying ETp via non-redox proteins\, such as rhodopsins or albumins (“dopable” proteins)\, pointing to peptides as efficient transport media; studying transport via\, including coupling to them\, can help to learn about protein ETp.
URL:https://ibecbarcelona.eu/event/ibec-seminar-david-cahen-2/
CATEGORIES:IBEC Seminar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20170306T120000
DTEND;TZID=Europe/Madrid:20170306T130000
DTSTAMP:20260405T234545
CREATED:20170222T083846Z
LAST-MODIFIED:20170303T081702Z
UID:27719-1488801600-1488805200@ibecbarcelona.eu
SUMMARY:IBEC Seminar: David Cahen
DESCRIPTION:Electron Transport across Peptides and Proteins\nProf. David Cahen\, Weizmann Institute of Science\nElectron transport (ETp)\, i.e.\, electronic conduction across peptides and proteins in a solid state–like configuration is surprisingly efficient\, and comparable to\, or at times even more efficient than via completely conjugated molecules of comparable length. Working with modified proteins and with homopeptides we find both cofactors and secondary structure to matter for ETp efficiency. An open question is if contact to the external world is the dominant factor\, or intra-protein transport. This is important\, also for electron transfer\, ET: nature regulates ET via redox chemistry\, i.e.\, injection and extraction of electrons; this is where ET and ETp are related\, because the analog in the latter is the coupling to the electrodes. In ET control over the process is achieved at the free energy price of a redox event\, but no redox process is required for ETp. This allows studying ETp via non-redox proteins\, such as rhodopsins or albumins (“dopable” proteins)\, pointing to peptides as efficient transport media; studying transport via\, including coupling to them\, can help to learn about protein ETp.
URL:https://ibecbarcelona.eu/event/ibec-seminar-david-cahen/
CATEGORIES:IBEC Seminar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20170329T120000
DTEND;TZID=Europe/Madrid:20170329T130000
DTSTAMP:20260405T234545
CREATED:20170308T135727Z
LAST-MODIFIED:20170308T135727Z
UID:96007-1490788800-1490792400@ibecbarcelona.eu
SUMMARY:IBEC Seminar: Aranzazu Villasante
DESCRIPTION:Cancer Engineering: Strategies to Engineer Predictable Tumor Models\nDr. Aranzazu Villasante\, Department of Biomedical Engineering\, Columbia University\, New York\nAlthough many drugs show promise in monolayer or in animal models systems\, most fail to translate in humans and this is because they lack of ability to replicate the human microenvironment in patients. In response to these limitations\, I have generated a set of predictable tissue-engineered (TE) models of cancer by using different strategies. Today\, I am going to focus on some of these approaches to engineer pediatric tumors in vitro. Firstly\, I will show a TE model of Ewing’s sarcoma (ES) within its bone niche. This particular strategy is based on engineered human bone by introducing osteoclasts in co-culture with osteoblasts in the 3-dimensional bone niche. This model mimics bone remodeling and recapitulates some of the features observed in the osteolytic process in cancer and also\, the effects of the therapeutic reagent Zoledronic acid observed in patients. The second strategy consists in designing biomaterials with the same tumor composition to mimic the biological and mechanical properties of tumors from patients. I have developed 3D porous collagen 1-hyaluronic acid scaffolds (Col1-HA scaffolds) for studies of tumor derivedexosomes\, which are known to be initiators of pre-metastatic niche formation in certain sites. Interestingly\, I found high levels of a critical mediator of ES growth and metastasis (EZH2) in exosomes isolated from both patients and TE model of ES. Alternatively\, we cultured TE models based on Col1-HA scaffolds into a mechanical loading bioreactor for better mimicking biomechanical forces in ES. We found that biomechanical stimuli modulate osteolytic-related proteins (i.e. RUNX2) and sensitivity to anticancer drugs\, such as Sorafenib. I will also explain the use of perfusion bioreactors and cell sheet engineering to develop a novel model of Neuroblastoma (NB) to study the effect of consolidative drugs\, such as Isotretinoin\, on tumor vasculature and stem-like cells. Here\, I will show the existence of sub-populations of NB cells with different levels of stemness properties; these levels are related to the capacity of stem-like cells to transdifferentiate and also\, to chemoresistance and relapse. Finally\, the take-home message of my talk will be that TE models can bridge the gap between 2D in vitro cultures and in vivo animal models in a predictive\, inexpensive and low timeconsuming fashion for successfully understand cancer biology and improve cancer treatments.
URL:https://ibecbarcelona.eu/event/ibec-seminar-aranzazu-villasante-2/
CATEGORIES:IBEC Seminar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20170329T120000
DTEND;TZID=Europe/Madrid:20170329T130000
DTSTAMP:20260405T234545
CREATED:20170308T135727Z
LAST-MODIFIED:20170308T135727Z
UID:28031-1490788800-1490792400@ibecbarcelona.eu
SUMMARY:IBEC Seminar: Aranzazu Villasante
DESCRIPTION:Cancer Engineering: Strategies to Engineer Predictable Tumor Models\nDr. Aranzazu Villasante\, Department of Biomedical Engineering\, Columbia University\, New York\nAlthough many drugs show promise in monolayer or in animal models systems\, most fail to translate in humans and this is because they lack of ability to replicate the human microenvironment in patients. In response to these limitations\, I have generated a set of predictable tissue-engineered (TE) models of cancer by using different strategies. Today\, I am going to focus on some of these approaches to engineer pediatric tumors in vitro. Firstly\, I will show a TE model of Ewing’s sarcoma (ES) within its bone niche. This particular strategy is based on engineered human bone by introducing osteoclasts in co-culture with osteoblasts in the 3-dimensional bone niche. This model mimics bone remodeling and recapitulates some of the features observed in the osteolytic process in cancer and also\, the effects of the therapeutic reagent Zoledronic acid observed in patients. The second strategy consists in designing biomaterials with the same tumor composition to mimic the biological and mechanical properties of tumors from patients. I have developed 3D porous collagen 1-hyaluronic acid scaffolds (Col1-HA scaffolds) for studies of tumor derivedexosomes\, which are known to be initiators of pre-metastatic niche formation in certain sites. Interestingly\, I found high levels of a critical mediator of ES growth and metastasis (EZH2) in exosomes isolated from both patients and TE model of ES. Alternatively\, we cultured TE models based on Col1-HA scaffolds into a mechanical loading bioreactor for better mimicking biomechanical forces in ES. We found that biomechanical stimuli modulate osteolytic-related proteins (i.e. RUNX2) and sensitivity to anticancer drugs\, such as Sorafenib. I will also explain the use of perfusion bioreactors and cell sheet engineering to develop a novel model of Neuroblastoma (NB) to study the effect of consolidative drugs\, such as Isotretinoin\, on tumor vasculature and stem-like cells. Here\, I will show the existence of sub-populations of NB cells with different levels of stemness properties; these levels are related to the capacity of stem-like cells to transdifferentiate and also\, to chemoresistance and relapse. Finally\, the take-home message of my talk will be that TE models can bridge the gap between 2D in vitro cultures and in vivo animal models in a predictive\, inexpensive and low timeconsuming fashion for successfully understand cancer biology and improve cancer treatments.
URL:https://ibecbarcelona.eu/event/ibec-seminar-aranzazu-villasante/
CATEGORIES:IBEC Seminar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20170519T100000
DTEND;TZID=Europe/Madrid:20170519T110000
DTSTAMP:20260405T234545
CREATED:20170425T125954Z
LAST-MODIFIED:20170425T125954Z
UID:28878-1495188000-1495191600@ibecbarcelona.eu
SUMMARY:IBEC Seminar: Verena Ruprecht
DESCRIPTION:Tuning cell and tissue dynamics by the biomechanical microenvironment\nDr. Verena Ruprecht\, Cell & Developmental Biology program\, CRG\, Barcelona (Spain)\nResearch in our lab is focused on the control of cell and tissue dynamics in 3D environments. We study how single cells process multifactorial mechanochemical information from their surrounding and generate adaptive output dynamics such as shape change\, cell polarization and migration that collectively impact on tissue development and morphogenesis. We use Zebrafish embryos and primary embryonic progenitor stem cells as a model system to study molecular and cellular mechanisms driving complex three-dimensional tissue rearrangements and patterning in the embryo. Our lab follows a highly interdisciplinary approach combining molecular and cell biological tools with quantitative imaging approaches and advanced fluorescence microscopy. We implement a dual experiment strategy of in vivo experiments and minimalistic in vitro culture assays that allow for reconstituting the complexity of tissue morphogenesis in simplified environments.\nIn this talk I will specifically focus on how the  3D cellular microenvironment modulates cytoskeletal dynamics and motile cell behaviour and how a combination of physics and biology can help to elucidate generic patterns in cell motility.
URL:https://ibecbarcelona.eu/event/ibec-seminar-verena-ruprecht/
CATEGORIES:IBEC Seminar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20170519T100000
DTEND;TZID=Europe/Madrid:20170519T110000
DTSTAMP:20260405T234545
CREATED:20170425T125954Z
LAST-MODIFIED:20170425T125954Z
UID:96045-1495188000-1495191600@ibecbarcelona.eu
SUMMARY:IBEC Seminar: Verena Ruprecht
DESCRIPTION:Tuning cell and tissue dynamics by the biomechanical microenvironment\nDr. Verena Ruprecht\, Cell & Developmental Biology program\, CRG\, Barcelona (Spain)\nResearch in our lab is focused on the control of cell and tissue dynamics in 3D environments. We study how single cells process multifactorial mechanochemical information from their surrounding and generate adaptive output dynamics such as shape change\, cell polarization and migration that collectively impact on tissue development and morphogenesis. We use Zebrafish embryos and primary embryonic progenitor stem cells as a model system to study molecular and cellular mechanisms driving complex three-dimensional tissue rearrangements and patterning in the embryo. Our lab follows a highly interdisciplinary approach combining molecular and cell biological tools with quantitative imaging approaches and advanced fluorescence microscopy. We implement a dual experiment strategy of in vivo experiments and minimalistic in vitro culture assays that allow for reconstituting the complexity of tissue morphogenesis in simplified environments.\nIn this talk I will specifically focus on how the  3D cellular microenvironment modulates cytoskeletal dynamics and motile cell behaviour and how a combination of physics and biology can help to elucidate generic patterns in cell motility.
URL:https://ibecbarcelona.eu/event/ibec-seminar-verena-ruprecht-2/
CATEGORIES:IBEC Seminar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20170602T100000
DTEND;TZID=Europe/Madrid:20170602T110000
DTSTAMP:20260405T234545
CREATED:20170529T132500Z
LAST-MODIFIED:20170529T132500Z
UID:96068-1496397600-1496401200@ibecbarcelona.eu
SUMMARY:IBEC Seminar:  Esteve Trias & Oscar Fariñas\, BTB
DESCRIPTION:Research challenges of the Barcelona Tissue Bank\n Esteve Trias\, Oscar Fariñas – Barcelona Tissue Bank (Banc de Sang I Teixits)\nThe Barcelona Tissue Bank (BTB) is a multi-tissue bank which belongs to the Banc de Sang i Teixits (BST)\, a public company of the Department of Health of the Generalitat de Catalunya\, whose mission is to ensure the supply and proper use of blood and Tissue in Catalonia.\nThe BTB controls the entire process of donation and transplantation globally\, from the process of detection and evaluation of the potential donor\, obtention or extraction\, processing of the different tissues\, storage and distribution until transplantation.\nIn the BTB we can distinguish five major banks: ocular\, cardiovascular\, skin\, musculoskeletal and reproductive.\nMusculoskeletal tissue bank represents 50% of the activity of BTB\, covering approximately 85% of transplanted tissue in the Spanish state. Different types of tissues are processed through a decontamination process to ensure maximum security. The purpose of the great variety of processed tissues is to meet the different needs of surgeons\, being the most common ligament reconstruction\, filling bone defects\, tumour surgery and meniscal transplantation.\nResearch\, development and innovation of new products and processes are constant priorities to provide the best solution for patients by setting up different lines of R & D in the short\, medium and long term.
URL:https://ibecbarcelona.eu/event/seminario-de-id-del-banc-de-sang-i-teixits-bst-2/
LOCATION:IBEC\, floor 11\, Tower I\, Baldiri Reixac 4-8\, 08028 Barcelona\, Spain
CATEGORIES:IBEC Seminar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20170602T100000
DTEND;TZID=Europe/Madrid:20170602T110000
DTSTAMP:20260405T234545
CREATED:20170529T132500Z
LAST-MODIFIED:20170530T125041Z
UID:29677-1496397600-1496401200@ibecbarcelona.eu
SUMMARY:IBEC Seminar:  Esteve Trias & Oscar Fariñas\, BTB
DESCRIPTION:Research challenges of the Barcelona Tissue Bank\n Esteve Trias\, Oscar Fariñas – Barcelona Tissue Bank (Banc de Sang I Teixits)\nThe Barcelona Tissue Bank (BTB) is a multi-tissue bank which belongs to the Banc de Sang i Teixits (BST)\, a public company of the Department of Health of the Generalitat de Catalunya\, whose mission is to ensure the supply and proper use of blood and Tissue in Catalonia.\nThe BTB controls the entire process of donation and transplantation globally\, from the process of detection and evaluation of the potential donor\, obtention or extraction\, processing of the different tissues\, storage and distribution until transplantation.\nIn the BTB we can distinguish five major banks: ocular\, cardiovascular\, skin\, musculoskeletal and reproductive.\nMusculoskeletal tissue bank represents 50% of the activity of BTB\, covering approximately 85% of transplanted tissue in the Spanish state. Different types of tissues are processed through a decontamination process to ensure maximum security. The purpose of the great variety of processed tissues is to meet the different needs of surgeons\, being the most common ligament reconstruction\, filling bone defects\, tumour surgery and meniscal transplantation.\nResearch\, development and innovation of new products and processes are constant priorities to provide the best solution for patients by setting up different lines of R & D in the short\, medium and long term.
URL:https://ibecbarcelona.eu/event/seminario-de-id-del-banc-de-sang-i-teixits-bst/
LOCATION:IBEC\, floor 11\, Tower I\, Baldiri Reixac 4-8\, 08028 Barcelona\, Spain
CATEGORIES:IBEC Seminar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20170714T100000
DTEND;TZID=Europe/Madrid:20170714T110000
DTSTAMP:20260405T234545
CREATED:20170630T073735Z
LAST-MODIFIED:20170630T073735Z
UID:96075-1500026400-1500030000@ibecbarcelona.eu
SUMMARY:IBEC Seminar: Maria Vinaixa
DESCRIPTION:Mass spectrometry and metabolomics data analysis for synthetic biology\n Maria Vinaixa\, Synthetic Biology for Fine and Speciality Chemicals (SYNBIOCHEM)\, Manchester Institute of Biotechnology\nSynthetic biology builds upon the creation of new biologically inspired standardized parts that can be put together using design or simulations tools to build circuits that will create de-novo biological functions or modify existing ones. Using synthetic biology\, microbial cell factories can be engineered to provide new sustainable bio-routes for the production of fuels\, biopharmaceuticals\, fragrances\, and food flavors among others. In this regard\, the SYNBIOCHEM Centre (www.synbiochem.co.uk) has set-up an automated Design/Build/Test/Learn pipeline designed to provide access to target fine chemicals through iterative\, rapid and predictable engineering of production pathways and microbial strains. This pipeline moves from Design of new parts (e.g. enzymes\, regulatory circuits\, metabolic pathways)\, through to combinatorial high-throughput Build approaches (directed evolution\, components\, pathways and strain assembly) and high-throughput analytics in Test (product extraction\, instrumental analysis\, data analysis and sharing) feeding back to improved designs via an active Learning stage at each cycle iteration. This pipeline allows unprecedented possibilities for retro biosynthesis of non-natural products and for the expansion of natural products chemical diversity. Screening for the small-molecule structure diversity emanating from such pipeline is an analytically daunting challenge. In this regard\, mass spectrometry (MS) is a key analytical technology offering the high throughput screening capabilities as well as the versatility needed to cope with such chemical diversity. However\, curating MS data and merging it with all other types of data generated through iterative D/B/T/L cycle so that it can be used to learn and redesign remains a challenge. Despite Metabolomics has powered computational solutions for MS data analysis; such solutions do only partially cover the needs within a synthetic biology context. Thus\, we are building the next generation computational toolbox for MS data analysis and storage so it can be harvested across the entire pipeline. In this seminar\, main capabilities and functionalities on such toolbox are going to be discussed.
URL:https://ibecbarcelona.eu/event/ibec-seminar-maria-vinaixa-2/
LOCATION:IBEC\, floor 11\, Tower I\, Baldiri Reixac 4-8\, 08028 Barcelona\, Spain
CATEGORIES:IBEC Seminar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20170714T100000
DTEND;TZID=Europe/Madrid:20170714T110000
DTSTAMP:20260405T234545
CREATED:20170630T073735Z
LAST-MODIFIED:20170630T073817Z
UID:30091-1500026400-1500030000@ibecbarcelona.eu
SUMMARY:IBEC Seminar: Maria Vinaixa
DESCRIPTION:Mass spectrometry and metabolomics data analysis for synthetic biology\n Maria Vinaixa\, Synthetic Biology for Fine and Speciality Chemicals (SYNBIOCHEM)\, Manchester Institute of Biotechnology\nSynthetic biology builds upon the creation of new biologically inspired standardized parts that can be put together using design or simulations tools to build circuits that will create de-novo biological functions or modify existing ones. Using synthetic biology\, microbial cell factories can be engineered to provide new sustainable bio-routes for the production of fuels\, biopharmaceuticals\, fragrances\, and food flavors among others. In this regard\, the SYNBIOCHEM Centre (www.synbiochem.co.uk) has set-up an automated Design/Build/Test/Learn pipeline designed to provide access to target fine chemicals through iterative\, rapid and predictable engineering of production pathways and microbial strains. This pipeline moves from Design of new parts (e.g. enzymes\, regulatory circuits\, metabolic pathways)\, through to combinatorial high-throughput Build approaches (directed evolution\, components\, pathways and strain assembly) and high-throughput analytics in Test (product extraction\, instrumental analysis\, data analysis and sharing) feeding back to improved designs via an active Learning stage at each cycle iteration. This pipeline allows unprecedented possibilities for retro biosynthesis of non-natural products and for the expansion of natural products chemical diversity. Screening for the small-molecule structure diversity emanating from such pipeline is an analytically daunting challenge. In this regard\, mass spectrometry (MS) is a key analytical technology offering the high throughput screening capabilities as well as the versatility needed to cope with such chemical diversity. However\, curating MS data and merging it with all other types of data generated through iterative D/B/T/L cycle so that it can be used to learn and redesign remains a challenge. Despite Metabolomics has powered computational solutions for MS data analysis; such solutions do only partially cover the needs within a synthetic biology context. Thus\, we are building the next generation computational toolbox for MS data analysis and storage so it can be harvested across the entire pipeline. In this seminar\, main capabilities and functionalities on such toolbox are going to be discussed.
URL:https://ibecbarcelona.eu/event/ibec-seminar-maria-vinaixa/
LOCATION:IBEC\, floor 11\, Tower I\, Baldiri Reixac 4-8\, 08028 Barcelona\, Spain
CATEGORIES:IBEC Seminar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20170725T100000
DTEND;TZID=Europe/Madrid:20170725T110000
DTSTAMP:20260405T234545
CREATED:20170717T120502Z
LAST-MODIFIED:20170717T120502Z
UID:96085-1500976800-1500980400@ibecbarcelona.eu
SUMMARY:IBEC Seminar: Ronen Zaidel-Bar
DESCRIPTION:Regulation of actomyosin contractility in C. elegans\nRonen Zaidel-Bar\, Mechanobiology Institute Singapore and Tel-Aviv University Medical School\nThe actomyosin cortex is responsible for cell shape and for dynamic processes such as cell polarization and cytokinesis. We are studying the regulation of cortical contractility in the C. elegans zygote\, using genetic loss of function and live-imaging. In my talk\, I will discuss recent findings regarding two proteins: the actin cross-linking protein plastin (PLST-1) and the transmembrane receptor E-cadherin (HMR-1). Consistent with previous in-vitro reconstitution studies\, we show that an optimal level of cross-linking by plastin is required for the generation of coordinated long-range contractions in the cortex; without the connectivity afforded by plastin\, zygote polarization and cytokinesis are severely perturbed. E-cadherin is well known for its role as a cell-cell adhesion receptor. \nSurprisingly\, we discovered a role for non-junctional E-cadherin clusters in regulating cortical contractility. E-cadherin clusters inhibit RhoA and non-muscle myosin II activity at the cortex and form a physical barrier that slows actin flows. In the absence of non-junctional E-cadherin cytokinesis proceeds faster\, but the cortex is also at a risk of detaching from the plasma membrane. Thus\, our studies in the C. elegans zygote are shedding light on structural and regulatory mechanisms underlying cortex function.
URL:https://ibecbarcelona.eu/event/ibec-seminar-ronen-zaidel-bar-2/
LOCATION:IBEC\, floor 11\, Tower I\, Baldiri Reixac 4-8\, 08028 Barcelona\, Spain
CATEGORIES:IBEC Seminar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20170725T100000
DTEND;TZID=Europe/Madrid:20170725T110000
DTSTAMP:20260405T234545
CREATED:20170717T120502Z
LAST-MODIFIED:20170717T120502Z
UID:30583-1500976800-1500980400@ibecbarcelona.eu
SUMMARY:IBEC Seminar: Ronen Zaidel-Bar
DESCRIPTION:Regulation of actomyosin contractility in C. elegans\nRonen Zaidel-Bar\, Mechanobiology Institute Singapore and Tel-Aviv University Medical School\nThe actomyosin cortex is responsible for cell shape and for dynamic processes such as cell polarization and cytokinesis. We are studying the regulation of cortical contractility in the C. elegans zygote\, using genetic loss of function and live-imaging. In my talk\, I will discuss recent findings regarding two proteins: the actin cross-linking protein plastin (PLST-1) and the transmembrane receptor E-cadherin (HMR-1). Consistent with previous in-vitro reconstitution studies\, we show that an optimal level of cross-linking by plastin is required for the generation of coordinated long-range contractions in the cortex; without the connectivity afforded by plastin\, zygote polarization and cytokinesis are severely perturbed. E-cadherin is well known for its role as a cell-cell adhesion receptor. \nSurprisingly\, we discovered a role for non-junctional E-cadherin clusters in regulating cortical contractility. E-cadherin clusters inhibit RhoA and non-muscle myosin II activity at the cortex and form a physical barrier that slows actin flows. In the absence of non-junctional E-cadherin cytokinesis proceeds faster\, but the cortex is also at a risk of detaching from the plasma membrane. Thus\, our studies in the C. elegans zygote are shedding light on structural and regulatory mechanisms underlying cortex function.
URL:https://ibecbarcelona.eu/event/ibec-seminar-ronen-zaidel-bar/
LOCATION:IBEC\, floor 11\, Tower I\, Baldiri Reixac 4-8\, 08028 Barcelona\, Spain
CATEGORIES:IBEC Seminar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20170928T143000
DTEND;TZID=Europe/Madrid:20170928T153000
DTSTAMP:20260405T234545
CREATED:20170922T075539Z
LAST-MODIFIED:20170922T075539Z
UID:96099-1506609000-1506612600@ibecbarcelona.eu
SUMMARY:IBEC Seminar: Silvain Muller\, RegenHu
DESCRIPTION:Bioprinting Software for the RegenHU 3DBioprinting System\nSilvain Muller\, RegenHu\nBioprinting is a dynamic and exciting stage of evolution where\, recently\, considerable progress has been accomplished globally in the field of tissue engineering and bioprinting. These developments have in turn led to ground-breaking advancements in Bioprinting leading from fundamental research to Applied research and Clinical testing. Key components in the successful transition of this evolution are the software tools specifically designed to enable interaction between the hardware\, the biology and the users. \nDuring this seminar Silvain Muller from RegenHu will describe the capabilities of our 3D Bioprinter (3D Discovery) and will perform a presentation of the software package associated that that enables the design of complex structures and scaffolds and the transformation of DICOM images to 3D-bioprinted constructs.
URL:https://ibecbarcelona.eu/event/ibec-seminar-silvain-muller-regenhu-2/
LOCATION:IBEC\, floor 11\, Tower I\, Baldiri Reixac 4-8\, 08028 Barcelona\, Spain
CATEGORIES:IBEC Seminar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20170928T143000
DTEND;TZID=Europe/Madrid:20170928T153000
DTSTAMP:20260405T234545
CREATED:20170922T075539Z
LAST-MODIFIED:20170922T075807Z
UID:31465-1506609000-1506612600@ibecbarcelona.eu
SUMMARY:IBEC Seminar: Silvain Muller\, RegenHu
DESCRIPTION:Bioprinting Software for the RegenHU 3DBioprinting System\nSilvain Muller\, RegenHu\nBioprinting is a dynamic and exciting stage of evolution where\, recently\, considerable progress has been accomplished globally in the field of tissue engineering and bioprinting. These developments have in turn led to ground-breaking advancements in Bioprinting leading from fundamental research to Applied research and Clinical testing. Key components in the successful transition of this evolution are the software tools specifically designed to enable interaction between the hardware\, the biology and the users. \nDuring this seminar Silvain Muller from RegenHu will describe the capabilities of our 3D Bioprinter (3D Discovery) and will perform a presentation of the software package associated that that enables the design of complex structures and scaffolds and the transformation of DICOM images to 3D-bioprinted constructs.
URL:https://ibecbarcelona.eu/event/ibec-seminar-silvain-muller-regenhu/
LOCATION:IBEC\, floor 11\, Tower I\, Baldiri Reixac 4-8\, 08028 Barcelona\, Spain
CATEGORIES:IBEC Seminar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20171006T100000
DTEND;TZID=Europe/Madrid:20171006T110000
DTSTAMP:20260405T234545
CREATED:20170926T091948Z
LAST-MODIFIED:20170926T091948Z
UID:31487-1507284000-1507287600@ibecbarcelona.eu
SUMMARY:IBEC Seminar: Fabio Variola
DESCRIPTION:At the intersection of biomaterials\, surface science and medicine\nFabio Variola\, Associate Professor\, Biomedical Engineering\, Cellular and Molecular Medicine\, University of Ottawa\nIn the quest for the next generation of functional biomaterials and new solutions in health-related research\, investigators have sought inspiration from nature by developing better performing bio-derived materials (e.g. collagen\, chitosan)\, reproducing naturally occurring micro and nanostructures (e.g. nanoporosity of collagen-apatite interfaces in bone\, ECM nanotopography) and devising strategies that mimic naturally occurring phenomena (e.g. mussel attachment). In this context\, our team has employed bio-derived materials and bio-inspired structures towards the creation of platforms and interfaces to investigate and control cellular events. In particular\, we successfully reproduced a bioactive nanoporosity on titanium\, the gold standard in medicine\, by simple chemical and electrochemical methods\, capable of positively affecting cell activity providing antibacterial properties. Anodization permitted not only to create semiordered nanotubular surfaces which can be tuned in terms of diameter and spacing\, but also a nanometric 3-dimensional hierarchical surface that mimics that of biologically successful life forms such as diatoms. Moreover\, we are currently working on understanding the effects on cells of poly(dopamine)\, an adhesive polymer derived from mussels\, as a multifunctional layer for direct cueing to cells. In parallel\, our team has also contributed to the development of collagen- and chitosan-based materials for applications ranging from cardiac and neuronal tissue engineering to synthetic blood vessels and drug delivery platforms.
URL:https://ibecbarcelona.eu/event/ibec-seminar-fabio-variola/
LOCATION:IBEC\, floor 11\, Tower I\, Baldiri Reixac 4-8\, 08028 Barcelona\, Spain
CATEGORIES:IBEC Seminar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20171006T100000
DTEND;TZID=Europe/Madrid:20171006T110000
DTSTAMP:20260405T234545
CREATED:20170926T091948Z
LAST-MODIFIED:20170926T091948Z
UID:96102-1507284000-1507287600@ibecbarcelona.eu
SUMMARY:IBEC Seminar: Fabio Variola
DESCRIPTION:At the intersection of biomaterials\, surface science and medicine\nFabio Variola\, Associate Professor\, Biomedical Engineering\, Cellular and Molecular Medicine\, University of Ottawa\nIn the quest for the next generation of functional biomaterials and new solutions in health-related research\, investigators have sought inspiration from nature by developing better performing bio-derived materials (e.g. collagen\, chitosan)\, reproducing naturally occurring micro and nanostructures (e.g. nanoporosity of collagen-apatite interfaces in bone\, ECM nanotopography) and devising strategies that mimic naturally occurring phenomena (e.g. mussel attachment). In this context\, our team has employed bio-derived materials and bio-inspired structures towards the creation of platforms and interfaces to investigate and control cellular events. In particular\, we successfully reproduced a bioactive nanoporosity on titanium\, the gold standard in medicine\, by simple chemical and electrochemical methods\, capable of positively affecting cell activity providing antibacterial properties. Anodization permitted not only to create semiordered nanotubular surfaces which can be tuned in terms of diameter and spacing\, but also a nanometric 3-dimensional hierarchical surface that mimics that of biologically successful life forms such as diatoms. Moreover\, we are currently working on understanding the effects on cells of poly(dopamine)\, an adhesive polymer derived from mussels\, as a multifunctional layer for direct cueing to cells. In parallel\, our team has also contributed to the development of collagen- and chitosan-based materials for applications ranging from cardiac and neuronal tissue engineering to synthetic blood vessels and drug delivery platforms.
URL:https://ibecbarcelona.eu/event/ibec-seminar-fabio-variola-2/
LOCATION:IBEC\, floor 11\, Tower I\, Baldiri Reixac 4-8\, 08028 Barcelona\, Spain
CATEGORIES:IBEC Seminar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20171011T090000
DTEND;TZID=Europe/Madrid:20171011T130000
DTSTAMP:20260405T234545
CREATED:20171006T095729Z
LAST-MODIFIED:20171006T095729Z
UID:96110-1507712400-1507726800@ibecbarcelona.eu
SUMMARY:Extra IBEC Seminar: Multimode Reader User Day
DESCRIPTION:Multimode Reader User Day\nStephan Haberstock\, Detection Specialist\, Tecan\nCore Facilities would like to invite you to a user day for multimode microplate readers. \nThe programme will offer practical insights on the following topics:\n• Introduction to the basic detection modes (Absorbance\, Fluorescence\, Luminescence) and advanced assays like FRET\, TRF\, and TR-FRET\n• Infinite 200 Pro\, a multimode reader highly configurable.\n• Spark®\, the new multimode readers from Tecan & application based configurations for: \no cell assays\no fluorescence assays\no luminescence assays\no nucleic acid analysis \nAfter the presentations we are happy to answer your specific questions & help you optimizing your personal methods. And\, obviously\, you’ll be able to test our readers on site!
URL:https://ibecbarcelona.eu/event/extra-ibec-seminar-multimode-reader-user-day-2/
LOCATION:IBEC\, floor 11\, Tower I\, Baldiri Reixac 4-8\, 08028 Barcelona\, Spain
CATEGORIES:IBEC Seminar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20171011T090000
DTEND;TZID=Europe/Madrid:20171011T130000
DTSTAMP:20260405T234545
CREATED:20171006T095729Z
LAST-MODIFIED:20171006T095729Z
UID:38142-1507712400-1507726800@ibecbarcelona.eu
SUMMARY:Extra IBEC Seminar: Multimode Reader User Day
DESCRIPTION:Multimode Reader User Day\nStephan Haberstock\, Detection Specialist\, Tecan\nCore Facilities would like to invite you to a user day for multimode microplate readers. \nThe programme will offer practical insights on the following topics:\n• Introduction to the basic detection modes (Absorbance\, Fluorescence\, Luminescence) and advanced assays like FRET\, TRF\, and TR-FRET\n• Infinite 200 Pro\, a multimode reader highly configurable.\n• Spark®\, the new multimode readers from Tecan & application based configurations for: \no cell assays\no fluorescence assays\no luminescence assays\no nucleic acid analysis \nAfter the presentations we are happy to answer your specific questions & help you optimizing your personal methods. And\, obviously\, you’ll be able to test our readers on site!
URL:https://ibecbarcelona.eu/event/extra-ibec-seminar-multimode-reader-user-day/
LOCATION:IBEC\, floor 11\, Tower I\, Baldiri Reixac 4-8\, 08028 Barcelona\, Spain
CATEGORIES:IBEC Seminar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20171018T100000
DTEND;TZID=Europe/Madrid:20171018T110000
DTSTAMP:20260405T234545
CREATED:20170926T130337Z
LAST-MODIFIED:20170926T130337Z
UID:96106-1508320800-1508324400@ibecbarcelona.eu
SUMMARY:IBEC Seminar: Arpita Upadhyaya
DESCRIPTION:Push\, pull and sense: Forces and mechanosensing in immune cells\nArpita Upadhyaya\, Associate Professor\, Department of Physics\, IPST\, University of Maryland\nThe activation of lymphocytes is an essential step in the adaptive immune response. Lymphocyte activation involves the binding of specialized receptors (TCR in T cells and BCR in B cells) with antigen on the surface of antigen presenting cells. This leads to changes in cell morphology and the movement and assembly of receptors\, scaffold proteins and enzymes into signaling microclusters\, which are essential for immune cell activation. During this process\, cells of the immune system interact with structures that possess a diverse range of physical properties. I will summarize our recent studies from a biophysical perspective that examine how T cells and B cells respond to physical cues such as stiffness\, topography and ligand mobility. Specifically\, I will highlight the distinct roles of the actin and microtubule cytoskeleton in the exertion of mechanical stresses that support signaling activation\, microcluster assembly and receptor movement in T and B lymphocytes.
URL:https://ibecbarcelona.eu/event/ibec-seminar-arpita-upadhyaya-2/
LOCATION:IBEC\, floor 11\, Tower I\, Baldiri Reixac 4-8\, 08028 Barcelona\, Spain
CATEGORIES:IBEC Seminar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20171018T100000
DTEND;TZID=Europe/Madrid:20171018T110000
DTSTAMP:20260405T234545
CREATED:20170926T130337Z
LAST-MODIFIED:20170926T130337Z
UID:31495-1508320800-1508324400@ibecbarcelona.eu
SUMMARY:IBEC Seminar: Arpita Upadhyaya
DESCRIPTION:Push\, pull and sense: Forces and mechanosensing in immune cells\nArpita Upadhyaya\, Associate Professor\, Department of Physics\, IPST\, University of Maryland\nThe activation of lymphocytes is an essential step in the adaptive immune response. Lymphocyte activation involves the binding of specialized receptors (TCR in T cells and BCR in B cells) with antigen on the surface of antigen presenting cells. This leads to changes in cell morphology and the movement and assembly of receptors\, scaffold proteins and enzymes into signaling microclusters\, which are essential for immune cell activation. During this process\, cells of the immune system interact with structures that possess a diverse range of physical properties. I will summarize our recent studies from a biophysical perspective that examine how T cells and B cells respond to physical cues such as stiffness\, topography and ligand mobility. Specifically\, I will highlight the distinct roles of the actin and microtubule cytoskeleton in the exertion of mechanical stresses that support signaling activation\, microcluster assembly and receptor movement in T and B lymphocytes.
URL:https://ibecbarcelona.eu/event/ibec-seminar-arpita-upadhyaya/
LOCATION:IBEC\, floor 11\, Tower I\, Baldiri Reixac 4-8\, 08028 Barcelona\, Spain
CATEGORIES:IBEC Seminar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20171218T120000
DTEND;TZID=Europe/Madrid:20171218T130000
DTSTAMP:20260405T234545
CREATED:20171123T104034Z
LAST-MODIFIED:20171123T104034Z
UID:96138-1513598400-1513602000@ibecbarcelona.eu
SUMMARY:IBEC Seminar: Jonel Trebicka
DESCRIPTION:Liver fibrosis and Portal hypertension\nProf. Jonel Trebicka\, Laboratory for Liver Fibrosis and Portal Hypertension\, Dept of Internal Medicine\, University of Bonn\nIn patients with chronic liver disease\, portal hypertension and progressive fibrosis are concomitant pathological processes interacting with each-other and leading to severe complications. The mechanics of matrix and the distinct response of different hepatic cell types contribute in the development of liver injury and cancer. Moreover\, cellular mechanics play a crucial role on the remodeling of matrix in chronic liver disease. Interruption of the liver injury either by treating the initial liver injury and addressing the perpetuating risk factors will improve both fibrosis and prevent or ameliorate portal hypertension. Currently\, after the successful cure of viral hepatitis\, lifestyle-related liver damage due to chronic alcoholism or morbid obesity will remain the main factor leading to liver fibrosis and portal hypertension. Even though\, the basic pathogenetic mechanisms of development of fibrosis and portal hypertension are similar. Especially RhoA/Rho-kinase pathway is crucially involved in the pathogenetic processes inside and outside the liver. RhoA/Rho-kinase is crucial in mechanics of cells\, and the modulation of these targets has been evaluated in different animal models. Also\, some well-established drugs\, which are used in humans for other indications (for example\, statins)\, are promising if applied early and concomitantly to standard therapy. In the future\, more cell-specific targeting and personalized strategies must be considered to avoid progression of disease and complications.
URL:https://ibecbarcelona.eu/event/ibec-seminar-jonel-trebicka-4/
LOCATION:IBEC\, floor 11\, Tower I\, Baldiri Reixac 4-8\, 08028 Barcelona\, Spain
CATEGORIES:IBEC Seminar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20171218T120000
DTEND;TZID=Europe/Madrid:20171218T130000
DTSTAMP:20260405T234545
CREATED:20171123T104034Z
LAST-MODIFIED:20171127T103555Z
UID:56469-1513598400-1513602000@ibecbarcelona.eu
SUMMARY:IBEC Seminar: Jonel Trebicka
DESCRIPTION:Liver fibrosis and Portal hypertension\nProf. Jonel Trebicka\, Laboratory for Liver Fibrosis and Portal Hypertension\, Dept of Internal Medicine\, University of Bonn\nIn patients with chronic liver disease\, portal hypertension and progressive fibrosis are concomitant pathological processes interacting with each-other and leading to severe complications. The mechanics of matrix and the distinct response of different hepatic cell types contribute in the development of liver injury and cancer. Moreover\, cellular mechanics play a crucial role on the remodeling of matrix in chronic liver disease. Interruption of the liver injury either by treating the initial liver injury and addressing the perpetuating risk factors will improve both fibrosis and prevent or ameliorate portal hypertension. Currently\, after the successful cure of viral hepatitis\, lifestyle-related liver damage due to chronic alcoholism or morbid obesity will remain the main factor leading to liver fibrosis and portal hypertension. Even though\, the basic pathogenetic mechanisms of development of fibrosis and portal hypertension are similar. Especially RhoA/Rho-kinase pathway is crucially involved in the pathogenetic processes inside and outside the liver. RhoA/Rho-kinase is crucial in mechanics of cells\, and the modulation of these targets has been evaluated in different animal models. Also\, some well-established drugs\, which are used in humans for other indications (for example\, statins)\, are promising if applied early and concomitantly to standard therapy. In the future\, more cell-specific targeting and personalized strategies must be considered to avoid progression of disease and complications.
URL:https://ibecbarcelona.eu/event/ibec-seminar-jonel-trebicka/
LOCATION:IBEC\, floor 11\, Tower I\, Baldiri Reixac 4-8\, 08028 Barcelona\, Spain
CATEGORIES:IBEC Seminar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20180112T100000
DTEND;TZID=Europe/Madrid:20180112T110000
DTSTAMP:20260405T234545
CREATED:20171228T101943Z
LAST-MODIFIED:20171228T101943Z
UID:57061-1515751200-1515754800@ibecbarcelona.eu
SUMMARY:IBEC Seminar: Dong-Pyo Kim
DESCRIPTION:Advances in Microfluidic Technology Driven by Materials\nDong-Pyo Kim\, POSTECH (Pohang University of Science & Technology)\, Korea\nAdvanced microreaction technologies have been achieved the best by chemistry and engineering together\, rather than either alone. This talk shows typical cases of innovative microreactor systems and process intensification by adopting multifunctional phenomena of materials and the specialty as well as by embracing newly emerging fabrication methods. \nDong-Pyo Kim is a professor of POSTECH and director of Center for Intelligent Microprocess of Pharmaceutical Synthesis. He obtained PhD in Chemistry at Temple University in 1991\, then post-doctoral research in University of Illinois at Urbana-Champaign (Materials S.E.)\, and came to Korea Research Institute of Chemical Technology as a senior researcher. Prior to POSTECH at 2012\, he had worked in Applied Chemistry at Chungnam National University for 17 years. His research has been based on materials chemistry of silicon-based resin. Since 2004\, he has devoted to a microreaction field\, currently covered the reactor design\, fabrication as well as continuous-flow syntheses in organics\, polymers and nanomaterials. He has published > 250 peer-reviewed papers and 30 patents. He received Academic Excellence Award by Korean Chemical Society (2017)\, POSTECHian Scientist of the Year (2016)\, The Great Scientist Award (2016) and Best 100 Scientific Achievement (2014\, 2007) by National Research Foundation.
URL:https://ibecbarcelona.eu/event/ibec-seminar-dong-pyo-kim/
LOCATION:IBEC\, floor 11\, Tower I\, Baldiri Reixac 4-8\, 08028 Barcelona\, Spain
CATEGORIES:IBEC Seminar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20180112T100000
DTEND;TZID=Europe/Madrid:20180112T110000
DTSTAMP:20260405T234545
CREATED:20171228T101943Z
LAST-MODIFIED:20171228T101943Z
UID:96148-1515751200-1515754800@ibecbarcelona.eu
SUMMARY:IBEC Seminar: Dong-Pyo Kim
DESCRIPTION:Advances in Microfluidic Technology Driven by Materials\nDong-Pyo Kim\, POSTECH (Pohang University of Science & Technology)\, Korea\nAdvanced microreaction technologies have been achieved the best by chemistry and engineering together\, rather than either alone. This talk shows typical cases of innovative microreactor systems and process intensification by adopting multifunctional phenomena of materials and the specialty as well as by embracing newly emerging fabrication methods. \nDong-Pyo Kim is a professor of POSTECH and director of Center for Intelligent Microprocess of Pharmaceutical Synthesis. He obtained PhD in Chemistry at Temple University in 1991\, then post-doctoral research in University of Illinois at Urbana-Champaign (Materials S.E.)\, and came to Korea Research Institute of Chemical Technology as a senior researcher. Prior to POSTECH at 2012\, he had worked in Applied Chemistry at Chungnam National University for 17 years. His research has been based on materials chemistry of silicon-based resin. Since 2004\, he has devoted to a microreaction field\, currently covered the reactor design\, fabrication as well as continuous-flow syntheses in organics\, polymers and nanomaterials. He has published > 250 peer-reviewed papers and 30 patents. He received Academic Excellence Award by Korean Chemical Society (2017)\, POSTECHian Scientist of the Year (2016)\, The Great Scientist Award (2016) and Best 100 Scientific Achievement (2014\, 2007) by National Research Foundation.
URL:https://ibecbarcelona.eu/event/ibec-seminar-dong-pyo-kim-2/
LOCATION:IBEC\, floor 11\, Tower I\, Baldiri Reixac 4-8\, 08028 Barcelona\, Spain
CATEGORIES:IBEC Seminar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20180118T150000
DTEND;TZID=Europe/Madrid:20180118T160000
DTSTAMP:20260405T234545
CREATED:20180115T090716Z
LAST-MODIFIED:20180115T090716Z
UID:96154-1516287600-1516291200@ibecbarcelona.eu
SUMMARY:IBEC Seminar: Gopi Shah
DESCRIPTION:Prospects of light sheet microscopy in developmental biology and cancer research\nGopi Shah (CRUK Cambridge Institute\, University of Cambridge)\nLight sheet microscopy is one of the fastest fluorescence imaging technologies available today. In the last decade\, it has emerged as an ideal technique for visualizing biological processes occurring at various time and length scales: rapid three-dimensional processes such as the beating zebrafish heart can be captured at >400 frames/sec\, large samples such as the developing zebrafish embryo (~0.7-1mm) can be imaged in toto at high resolution through multi-view imaging and delicate samples such as in vitro cultured 3D organoids can be monitored over days owing to its non-invasive nature. \nNonetheless\, most biological studies demand a higher imaging throughput in terms of sample size\, which has been a challenge for light sheet microscopy both in terms of microscope design and the volume of data generated. To address this\, we have developed customised light sheet microscopes with real-time image-processing engine that projects the 3D image volume onto a 2D map\, drastically reducing the amount of data generated as well as providing a panoramic view of the sample for ease of downstream analyses. We also designed a fluidic sample delivery system to pump embryos through the microscope\, enabling time-lapse imaging and screening of several samples simultaneously. Together\, these tools harness the high-speed imaging capability of a light sheet system to obtain multi-dimensional data from many samples\, essential for systematic population analysis. In my talk\, I will discuss how this work (a) has enabled integration of whole-sample live imaging\, genetic information and analysis of an ensemble of specimen to understand large-scale tissue movements during zebrafish embryogenesis and (b) facilitates my vision of establishing high-throughput imaging of organoids for understanding tumor cell dynamics and developing organoids as a model for image-based screening and therapeutics.
URL:https://ibecbarcelona.eu/event/ibec-seminar-gopi-shah-2/
LOCATION:IBEC\, floor 11\, Tower I\, Baldiri Reixac 4-8\, 08028 Barcelona\, Spain
CATEGORIES:IBEC Seminar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20180118T150000
DTEND;TZID=Europe/Madrid:20180118T160000
DTSTAMP:20260405T234545
CREATED:20180115T090716Z
LAST-MODIFIED:20180115T090716Z
UID:57187-1516287600-1516291200@ibecbarcelona.eu
SUMMARY:IBEC Seminar: Gopi Shah
DESCRIPTION:Prospects of light sheet microscopy in developmental biology and cancer research\nGopi Shah (CRUK Cambridge Institute\, University of Cambridge)\nLight sheet microscopy is one of the fastest fluorescence imaging technologies available today. In the last decade\, it has emerged as an ideal technique for visualizing biological processes occurring at various time and length scales: rapid three-dimensional processes such as the beating zebrafish heart can be captured at >400 frames/sec\, large samples such as the developing zebrafish embryo (~0.7-1mm) can be imaged in toto at high resolution through multi-view imaging and delicate samples such as in vitro cultured 3D organoids can be monitored over days owing to its non-invasive nature. \nNonetheless\, most biological studies demand a higher imaging throughput in terms of sample size\, which has been a challenge for light sheet microscopy both in terms of microscope design and the volume of data generated. To address this\, we have developed customised light sheet microscopes with real-time image-processing engine that projects the 3D image volume onto a 2D map\, drastically reducing the amount of data generated as well as providing a panoramic view of the sample for ease of downstream analyses. We also designed a fluidic sample delivery system to pump embryos through the microscope\, enabling time-lapse imaging and screening of several samples simultaneously. Together\, these tools harness the high-speed imaging capability of a light sheet system to obtain multi-dimensional data from many samples\, essential for systematic population analysis. In my talk\, I will discuss how this work (a) has enabled integration of whole-sample live imaging\, genetic information and analysis of an ensemble of specimen to understand large-scale tissue movements during zebrafish embryogenesis and (b) facilitates my vision of establishing high-throughput imaging of organoids for understanding tumor cell dynamics and developing organoids as a model for image-based screening and therapeutics.
URL:https://ibecbarcelona.eu/event/ibec-seminar-gopi-shah/
LOCATION:IBEC\, floor 11\, Tower I\, Baldiri Reixac 4-8\, 08028 Barcelona\, Spain
CATEGORIES:IBEC Seminar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20180131T153000
DTEND;TZID=Europe/Madrid:20180131T163000
DTSTAMP:20260405T234545
CREATED:20180125T121920Z
LAST-MODIFIED:20180125T121920Z
UID:96160-1517412600-1517416200@ibecbarcelona.eu
SUMMARY:IBEC Seminar: Gregory Lanza
DESCRIPTION:IBEC Seminar: Gregory Lanza\nGregory Lanza (Professor of Medicine\, Biomedical Engineering and Biology & Biomedical Sciences; Washington University)\nDr. Lanza is a full Professor of Medicine in the Cardiovascular Division of the School of Medicine\, with affiliations in the Department of Biomedical Engineering\, as well as Biology & Biomedical Sciences\, in Washington University.  He received a B.A. from Colby College\, both an M.S. and a Ph.D. from the Department of Poultry Science in University of Georgia Athens\, an M.D. from Northwest University\, and conducted his medical residency and cardiology specialization in Washington University Medical Center.  Dr. Lanza has been the recipient for a Searle Career Development Award\, as well as NCI Unconventional Innovation Program Awards in 2000\, 2002\, and 2003\, among several other recognitions.  He is also a Fellow of the American College of Cardiology.  Dr. Lanza is the Co-founder and Chief Scientific Officer for Kereos\, Inc.  He serves in the editorial board of Nanomedicine: Nanotechnology\, Biology\, & Medicine\, the International Journal of Green Nanotechnology: Biomedicine\, WIREs: Nanomedicine\, and Theranostics.
URL:https://ibecbarcelona.eu/event/ibec-seminar-gregory-lanza-2/
LOCATION:IBEC\, floor 11\, Tower I\, Baldiri Reixac 4-8\, 08028 Barcelona\, Spain
CATEGORIES:IBEC Seminar
ORGANIZER;CN="IBEC":MAILTO:www.ibecbarcelona.eu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20180131T153000
DTEND;TZID=Europe/Madrid:20180131T163000
DTSTAMP:20260405T234546
CREATED:20180125T121920Z
LAST-MODIFIED:20180129T101234Z
UID:57400-1517412600-1517416200@ibecbarcelona.eu
SUMMARY:IBEC Seminar: Gregory Lanza
DESCRIPTION:IBEC Seminar: Gregory Lanza\nGregory Lanza (Professor of Medicine\, Biomedical Engineering and Biology & Biomedical Sciences; Washington University)\nDr. Lanza is a full Professor of Medicine in the Cardiovascular Division of the School of Medicine\, with affiliations in the Department of Biomedical Engineering\, as well as Biology & Biomedical Sciences\, in Washington University.  He received a B.A. from Colby College\, both an M.S. and a Ph.D. from the Department of Poultry Science in University of Georgia Athens\, an M.D. from Northwest University\, and conducted his medical residency and cardiology specialization in Washington University Medical Center.  Dr. Lanza has been the recipient for a Searle Career Development Award\, as well as NCI Unconventional Innovation Program Awards in 2000\, 2002\, and 2003\, among several other recognitions.  He is also a Fellow of the American College of Cardiology.  Dr. Lanza is the Co-founder and Chief Scientific Officer for Kereos\, Inc.  He serves in the editorial board of Nanomedicine: Nanotechnology\, Biology\, & Medicine\, the International Journal of Green Nanotechnology: Biomedicine\, WIREs: Nanomedicine\, and Theranostics.
URL:https://ibecbarcelona.eu/event/ibec-seminar-gregory-lanza/
LOCATION:IBEC\, floor 11\, Tower I\, Baldiri Reixac 4-8\, 08028 Barcelona\, Spain
CATEGORIES:IBEC Seminar
ORGANIZER;CN="IBEC":MAILTO:www.ibecbarcelona.eu
END:VEVENT
END:VCALENDAR